Literature DB >> 18498273

Correlation between hormonal and lipid status in women in menopause.

Lejla Mesalić1, Emir Tupković, Sulejman Kendić, Devleta Balić.   

Abstract

It is widely accepted that menopause leads to changes in hormonal status, metabolism and lipid profile. The aim of this study was to analyze the influence of menopause on the concentrations of lipids, lipoproteins and, the influence of estradiol, progesterone, FSH, LH on lipid profile in menopausal women as well. The menopausal women had higher but non-significant (p>0,05) concentrations of total cholesterol, VLDL, LDL, and triglycerides than women with regular menstruation. The concentration of HDL was significantly lower in menopausal women than in women with regular menstruation (p<0,05). Also, the concentration of apolipoprotein B was significantly higher in menopausal women (p<0,05), but the concentrations of apolipoprotein and lipoprotein (a) were lower but without significance (p>0,05). Estrogen concentration has significant negative correlation with VLDL and triglycerides (p<0,05) and significant positive correlation with HDL (p<0,05) in menopausal women. Progesterone concentration has shown no correlation with concentrations of lipids and lipoproteins in menopause. We can conclude that menopause leads to changes in lipid profile by reducing HDL, and elevating apolipoprotein B levels, thus increasing the risk for cardiovascular disease. These changes were caused by reduction of estrogen concentrations in menopause.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498273      PMCID: PMC5698353          DOI: 10.17305/bjbms.2008.2980

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  20 in total

Review 1.  Coronary artery disease--is menopause a risk factor?

Authors:  C Gohlke-Bärwolf
Journal:  Basic Res Cardiol       Date:  2000       Impact factor: 17.165

2.  Changes in LDL density across the menopausal transition.

Authors:  M C Carr; K H Kim; A Zambon; E S Mitchell; N F Woods; C P Casazza; J Q Purnell; J E Hokanson; J D Brunzell; R S Schwartz
Journal:  J Investig Med       Date:  2000-07       Impact factor: 2.895

3.  Lipid and lipoprotein profile in menopausal transition. Effects of hormones, age and fat distribution.

Authors:  G Berg; V Mesch; L Boero; F Sayegh; M Prada; M Royer; M L Muzzio; L Schreier; N Siseles; H Benencia
Journal:  Horm Metab Res       Date:  2004-04       Impact factor: 2.936

4.  Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

Authors:  B Lamarche; S Moorjani; B Cantin; G R Dagenais; P J Lupien; J P Després
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-06       Impact factor: 8.311

5.  Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?

Authors:  W C Manfroi; A J Zago; M Campos; A Alves; M L Brisolara; J de Souza; R H Candiago; L Kirschnick; L Ribeiro; K Ordovás; C Leitão; R Cruz
Journal:  Arq Bras Cardiol       Date:  1999-06       Impact factor: 2.000

6.  Fat distribution and plasma lipid-lipoprotein concentrations in pre- and postmenopausal women.

Authors:  B A Gower; T R Nagy; M I Goran; M J Toth; E T Poehlman
Journal:  Int J Obes Relat Metab Disord       Date:  1998-07

Review 7.  MPA and postmenopausal coronary artery atherosclerosis revisited.

Authors:  Thomas B Clarkson; Susan E Appt
Journal:  Steroids       Date:  2003-11       Impact factor: 2.668

Review 8.  New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy.

Authors:  Sonia Davison; Susan R Davis
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

9.  Sex steroids and plasma lipoprotein levels in healthy women: The importance of androgens in the estrogen-deficient state.

Authors:  André P Van Beek; Florianne C de Ruijter-Heijstek; Hans Jansen; D Willem Erkelens; Tjerk W A de Bruin
Journal:  Metabolism       Date:  2004-02       Impact factor: 8.694

10.  An increased number of very-low-density lipoprotein particles is strongly associated with coronary heart disease in Japanese men, independently of intermediate-density lipoprotein or low-density lipoprotein.

Authors:  Shinji Koba; Tsutomu Hirano; Taro Sakaue; Hiroko Takeuchi; Mitsuru Adachi; Takashi Katagiri
Journal:  Coron Artery Dis       Date:  2002-08       Impact factor: 1.439

View more
  11 in total

1.  Lipoprotein and metabolite associations to breast cancer risk in the HUNT2 study.

Authors:  Julia Debik; Hartmut Schäfer; Trygve Andreassen; Feng Wang; Fang Fang; Claire Cannet; Manfred Spraul; Tone F Bathen; Guro F Giskeødegård
Journal:  Br J Cancer       Date:  2022-08-04       Impact factor: 9.075

2.  Ovarian Cancer Risk in Relation to Blood Cholesterol and Triglycerides.

Authors:  Britton Trabert; Cassandra A Hathaway; Megan S Rice; Eric B Rimm; Patrick M Sluss; Kathryn L Terry; Oana A Zeleznik; Shelley S Tworoger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-08-17       Impact factor: 4.090

3.  Cardiovascular and Osteoporosis Protection at Menopause with Lycopene: A Placebo-Controlled Double-Blind Randomized Clinical Trial.

Authors:  Meeta Meeta; Sudhaa Sharma; Jyothi Unni; Sunila Khandelwal; Ambuja Choranur; Sonia Malik
Journal:  J Midlife Health       Date:  2022-05-02

4.  A randomised controlled trial on hypolipidemic effects of Nigella Sativa seeds powder in menopausal women.

Authors:  Ramlah Mohamad Ibrahim; Nurul Syima Hamdan; Rozi Mahmud; Mustapha Umar Imam; Suraini Mohd Saini; Saiful Nizam Abd Rashid; Siti Aisyah Abd Ghafar; Latiffah Ab Latiff; Maznah Ismail
Journal:  J Transl Med       Date:  2014-03-31       Impact factor: 5.531

5.  Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats.

Authors:  Abbas Bakhteyari; Parvaneh Nikpour; Fatemah Sadat Mostafavi; Nahid Eskandari; Mohammad Matinfar; Sara Soleimani Asl; Roshanak Aboutorabi
Journal:  Int J Fertil Steril       Date:  2019-04-27

6.  CYP17A1 deficient XY mice display susceptibility to atherosclerosis, altered lipidomic profile and atypical sex development.

Authors:  Jeanette Erdmann; Zouhair Aherrahrou; Redouane Aherrahrou; Alexandra E Kulle; Natalia Alenina; Ralf Werner; Simeon Vens-Cappell; Michael Bader; Heribert Schunkert
Journal:  Sci Rep       Date:  2020-05-29       Impact factor: 4.379

7.  Sex-Dependent Dyslipidemia and Neuro-Humoral Alterations Leading to Further Cardiovascular Risk in Juvenile Obesity.

Authors:  Estefania Simoes; Joanna Correia-Lima; Elie Leal de Barros Calfat; Thais Zélia Dos Santos Otani; Daniel Augusto Correa Vasques; Victor Henrique Oyamada Otani; Pamela Bertolazzi; Cristiane Kochi; Marilia Seelaender; Ricardo Riyoiti Uchida
Journal:  Front Nutr       Date:  2021-02-12

8.  High low-density lipoprotein cholesterol level is associated with an increased risk of incident early-onset vasomotor symptoms.

Authors:  Hye Rin Choi; Yoosoo Chang; Yejin Kim; Jeonggyu Kang; Min-Jung Kwon; Ria Kwon; Ga-Young Lim; Kye-Hyun Kim; Hoon Kim; Yun Soo Hong; Di Zhao; Juhee Cho; Eliseo Guallar; Hyun-Young Park; Seungho Ryu
Journal:  Sci Rep       Date:  2022-08-27       Impact factor: 4.996

9.  The APOB gene polymorphism in the pathogenesis of gallstone disease in pre- and postmenopausal women.

Authors:  Karolina Rudzińska; Anna Bogacz; Daniel Kotrych; Hubert Wolski; Marian Majchrzycki; Agnieszka Seremak-Mrozikiewicz; Bogusław Kosiński; Bogusław Czerny
Journal:  Prz Menopauzalny       Date:  2015-03-25

10.  An Age-Period-Cohort Analysis of Biomarkers of Lifestyle-Related Diseases Using the National Health and Nutrition Survey in Japan, 1973-2018.

Authors:  Tasuku Okui
Journal:  Int J Environ Res Public Health       Date:  2020-11-04       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.